<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Insights Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Insights Imaging</journal-id><journal-title-group><journal-title>Insights into Imaging</journal-title></journal-title-group><issn pub-type="epub">1869-4101</issn><publisher><publisher-name>Springer Vienna</publisher-name><publisher-loc>Vienna</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40000513</article-id><article-id pub-id-type="pmc">PMC11861772</article-id>
<article-id pub-id-type="publisher-id">1923</article-id><article-id pub-id-type="doi">10.1186/s13244-025-01923-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Preoperative prediction of the Lauren classification in gastric cancer using automated nnU-Net and radiomics: a multicenter study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cao</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hu</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Haige</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Xuebing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Rong</surname><given-names>Chang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shuai</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Xiaomin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Kaicai</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chuanbin</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9481-9425</contrib-id><name><surname>Wu</surname><given-names>Xingwang</given-names></name><address><email>duobi2004@126.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03t1yn780</institution-id><institution-id institution-id-type="GRID">grid.412679.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1771 3402</institution-id><institution>Department of Radiology, </institution><institution>The First Affiliated Hospital of Anhui Medical University, </institution></institution-wrap>230022 Hefei, People&#x02019;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04pge2a40</institution-id><institution-id institution-id-type="GRID">grid.452511.6</institution-id><institution>Department of Radiology, </institution><institution>The Second Affiliated Hospital of Nanjing Medical University, </institution></institution-wrap>210011 Nanjing, People&#x02019;s Republic of China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04je70584</institution-id><institution-id institution-id-type="GRID">grid.489986.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 6473 1769</institution-id><institution>Department of Radiology, Anhui Provincial Children&#x02019;s Hospital, </institution><institution>Children&#x02019;s Hospital of Fudan University Anhui Hospital, </institution></institution-wrap>230051 Hefei, People&#x02019;s Republic of China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04pge2a40</institution-id><institution-id institution-id-type="GRID">grid.452511.6</institution-id><institution>Department of Pathology, </institution><institution>The Second Affiliated Hospital of Nanjing Medical University, </institution></institution-wrap>210011 Nanjing, People&#x02019;s Republic of China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04c4dkn09</institution-id><institution-id institution-id-type="GRID">grid.59053.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 9639</institution-id><institution>Department of Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, </institution><institution>University of Science and Technology of China, </institution></institution-wrap>230031 Hefei, People&#x02019;s Republic of China </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2025</year></pub-date><volume>16</volume><elocation-id>48</elocation-id><history><date date-type="received"><day>20</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">To develop and validate a deep learning model based on nnU-Net combined with radiomics to achieve autosegmentation of gastric cancer (GC) and preoperative prediction via the Lauren classification.</p></sec><sec><title>Methods</title><p id="Par2">Patients with a pathological diagnosis of GC were retrospectively enrolled in three medical centers. The nnU-Net autosegmentation model was developed using manually segmented datasets and evaluated by the Dice similarity coefficient (DSC). The CT images were processed by the nnU-Net model to obtain autosegmentation results and extract radiomic features. The least absolute shrinkage and selection operator (LASSO) method selects optimal features for calculating the Radscore and constructing a radiomic model. Clinical characteristics and the Radscore were integrated to construct a combined model. Model performance was evaluated via the receiver operating characteristic (ROC) curve.</p></sec><sec><title>Results</title><p id="Par3">A total of 433 GC patients were divided into the training set, internal validation set, external test set-1, and external test set-2. The nnU-Net model achieved a DSC of 0.79 in the test set. The areas under the curve (AUCs) of the internal validation set, external test set-1, and external test set-2 were 0.84, 0.83, and 0.81, respectively, for the radiomic model; and 0.81, 0.81, and 0.82, respectively, for the combined model. The AUCs of the radiomic and combined models showed no statistically significant difference (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). The radiomic model was selected as the optimal model.</p></sec><sec><title>Conclusions</title><p id="Par4">The nnU-Net model can efficiently and accurately achieve automatic segmentation of GCs. The radiomic model can preoperatively predict the Lauren classification of GC with high accuracy.</p></sec><sec><title>Critical relevance statement</title><p id="Par5">This study highlights the potential of nnU-Net combined with radiomics to noninvasively predict the Lauren classification in gastric cancer patients, enhancing personalized treatment strategies and improving patient management.</p></sec><sec><title>Key Points</title><p id="Par6">
<list list-type="bullet"><list-item><p id="Par7">The Lauren classification influences gastric cancer treatment and prognosis.</p></list-item><list-item><p id="Par8">The nnU-Net model reduces doctors&#x02019; manual segmentation errors and workload.</p></list-item><list-item><p id="Par9">Radiomics models aid in preoperative Lauren classification prediction for patients with gastric cancer.</p></list-item></list>
</p></sec><sec><title>Graphical Abstract</title><p id="Par10">
<graphic position="anchor" xlink:href="13244_2025_1923_Figa_HTML" id="d33e269"/>
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Gastric cancer</kwd><kwd>Deep learning</kwd><kwd>Radiomics</kwd><kwd>Computed tomography</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; European Society of Radiology (ESR) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par23">Gastric cancer (GC) is the fifth most common cancer and the fourth leading cause of cancer death worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. The Lauren classification system categorizes GC into two main types, namely, intestinal and diffuse types, which differ significantly in terms of pathological characteristics, prognosis, and treatment response [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. The Lauren classification provides clinical value for treatment decisions, with intestinal-type GC typically responding better to chemotherapy and having a better prognosis than diffuse-type GC does. Therefore, accurate preoperative prediction of the Lauren classification is crucial for formulating personalized treatment strategies.</p><p id="Par24">Currently, the main methods for preoperatively predicting the Lauren classification of GC include endoscopy, pathological biopsy, and molecular biomarker analysis. Endoscopy and biopsy provide accurate histological information and are crucial for diagnosis and treatment [<xref ref-type="bibr" rid="CR6">6</xref>]. However, these techniques have limitations, such as invasiveness, sampling errors, and contraindications in some patients. Noninvasive approaches, such as imaging techniques, are being explored as alternatives for preoperative Lauren classification prediction. However, these methods are still under investigation, and their clinical utility requires further validation [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par25">Radiomics extracts many quantitative features from medical images, reflecting tumor heterogeneity and biological behavior [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In recent years, radiomics has shown great potential in tumor diagnosis, prognosis prediction, and treatment response assessment [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>]. Traditional radiomic methods, which rely on the manual delineation of regions of interest (ROIs), are subjective and time-consuming [<xref ref-type="bibr" rid="CR16">16</xref>]. Automated segmentation techniques have emerged to address this issue. nnU-Net, a neural network based on the U-Net architecture, is specifically designed for medical image segmentation and can automatically adapt to different datasets, achieving efficient and accurate segmentation [<xref ref-type="bibr" rid="CR17">17</xref>]. Although nnU-Net has performed well in various medical image segmentation tasks, its application in predicting Lauren classification in GC remains to be explored.</p><p id="Par26">This study focuses on the use of an automated nnU-Net model to segment GCs from preoperative CT images and employs radiomic techniques to predict the Lauren classification, specifically distinguishing between the intestinal and diffuse types. The mixed-type Lauren classification is excluded because of its greater aggressiveness, increased lymph node metastasis, and different biological behavior than the intestinal and diffuse types, which could introduce complexities in model training and prediction [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. By incorporating multicenter data for external validation, we aimed to assess the generalizability and clinical applicability of the model. This approach aims to enhance the automation of segmentation and feature extraction, reduce subjective biases and workload, and provide a reliable and accurate model for the preoperative evaluation of GC.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><p id="Par27">This retrospective multicenter study was approved by the Institutional Review Boards (IRBs) of Center 1, Center 2, and Center 3. Informed consent was waived because of the retrospective nature of this study.</p><sec id="Sec3"><title>Study sample and design</title><p id="Par28">From June 2019 to March 2024, a total of 592 patients from three medical centers were screened. Based on the inclusion and exclusion criteria, 433 patients were ultimately included. The inclusion criteria were as follows: (1) patients with pathologically confirmed GC; (2) patients who underwent standard abdominal plain and enhanced CT scans within two weeks before surgery; (3) patients aged &#x02265;&#x02009;18 years; and (4) patients whose complete clinical data were available. The exclusion criteria were as follows: (1) received any antitumor treatment before surgery; (2) poor quality of enhanced CT images, such as unfilled stomach or significant motion artifacts; (3) maximum tumor diameter &#x0003c;&#x02009;1&#x02009;cm, as lesions smaller than 1&#x02009;cm are challenging to delineate precisely and can lead to reduced reliability of radiomic feature extraction, which is crucial for building accurate predictive models [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]; and (4) pathological Lauren classification as a mixed type. From the Center 1 cohort (<italic>n</italic>&#x02009;=&#x02009;314), 108 patients were randomly selected to train the nnU-Net model for automatic tumor segmentation. The Center 1 cohort was also used to train the clinical, radiomic, and combined clinical-radiomic models for the preoperative prediction of the Lauren classification in patients with GC, which were divided into a training set (<italic>n</italic>&#x02009;=&#x02009;219) and an internal validation set (<italic>n</italic>&#x02009;=&#x02009;95) at a 7:3 ratio. The cohorts from Center 2 (<italic>n</italic>&#x02009;=&#x02009;69) and Center 3 (<italic>n</italic>&#x02009;=&#x02009;50) were used for external testing of the models. The patient selection and study design workflow are illustrated in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>The flowchart of patient selection and study design</p></caption><graphic xlink:href="13244_2025_1923_Fig1_HTML" id="d33e436"/></fig></p></sec><sec id="Sec4"><title>CT imaging study protocol</title><p id="Par29">All patients fasted for at least 6&#x02009;hours before the CT examination and drank approximately 1000&#x02009;mL of water to distend the stomach. CT examinations were performed using either 64- or 128-slice scanners from different manufacturers, including Revolution CT, Optima CT680, and Discovery CT750 from GE Healthcare; IQon Spectral from Philips Health care; and Somatom Definition Flash from Siemens Healthineers. The CT scan parameters were as follows: tube voltages of 100&#x02013;120&#x02009;kV, tube currents of 120&#x02013;640&#x02009;mA, detector collimations of 0.6&#x02013;0.625&#x02009;mm, image matrix of 512&#x02009;&#x000d7;&#x02009;512, and slice thicknesses of 1&#x02013;1.25&#x02009;mm. Patients were scanned in the supine position for both plain and contrast-enhanced scans, covering the upper abdomen or whole abdomen. To standardize variations in CT slice thickness, all original images were reconstructed to a slice thickness of 5&#x02009;mm before analysis to ensure data consistency. A nonionic contrast agent (Ultravist 300 or Ioversol 320) was injected at a rate of 3.0&#x02009;mL/s at doses ranging from 1&#x02013;1.5&#x02009;mL/kg. Images were acquired at 20&#x02013;30&#x02009;s (arterial phase, AP), 60&#x02013;70&#x02009;s (portal venous phase, PP), and 180&#x02009;s (delayed phase, DP) after contrast injection.</p></sec><sec id="Sec5"><title>Assessment of clinical and radiological characteristics</title><p id="Par30">Through the electronic health records (EHR) system, the clinical and pathological data of patients, including sex, age, smoking history, alcohol consumption history, hypertension status, diabetes status, carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), and Lauren classification were collected. Abdominal CT images were obtained through the Picture Archiving and Communication System (PACS). Two radiologists (with 10 and 20 years of experience) independently and blindly assessed the radiological characteristics of all the images. Discrepancies were resolved through consensus discussions. The radiological characteristic measured was the maximum tumor diameter, defined as the longest linear distance measured on the largest cross-sectional area of the tumor on axial images [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec6"><title>Manual lesion segmentation</title><p id="Par31">The CT images of the portal venous phase of 108 randomly selected patients from the Center 1 cohort were manually segmented using ITK-SNAP software (version 3.8.0; <ext-link ext-link-type="uri" xlink:href="http://www.itksnap.org">http://www.itksnap.org</ext-link>) [<xref ref-type="bibr" rid="CR22">22</xref>] by two radiologists. The two radiologists delineated the lesions together, avoiding the inclusion of blood vessels and gastric contents. All annotations were reviewed by a third radiologist with 20 years of experience.</p></sec><sec id="Sec7"><title>Construction of the automatic segmentation model</title><p id="Par32">The nnU-Net is a deep learning model designed for efficient segmentation by automatically configuring the segmentation pipeline. The code used in this study is available at <ext-link ext-link-type="uri" xlink:href="http://github.com/MIC-DKFZ/nnUNet">http://github.com/MIC-DKFZ/nnUNet</ext-link>. We utilized the default configuration of nnU-Net and trained our model on the 3D full-resolution U-Net architecture. The network architecture of nnU-Net is depicted in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Network architecture of nnU-Net for automatic segmentation of GC lesions</p></caption><graphic xlink:href="13244_2025_1923_Fig2_HTML" id="d33e476"/></fig></p><p id="Par33">This study included a total of 108 patients with CT images and their corresponding manual segmentation labels, which were divided into training and validation sets (<italic>n</italic>&#x02009;=&#x02009;82) and a test set (<italic>n</italic>&#x02009;=&#x02009;26). Fivefold cross-validation was employed to fine-tune the model during the training process, and model performance was evaluated on the test set. The evaluation metrics included the dice similarity coefficient (DSC), intersection over union (IoU), precision, and recall.</p><p id="Par34">During the data preprocessing stage, the nnU-Net framework standardizes the original images on the basis of task characteristics. First, the images were resampled to a voxel size of 5.0 &#x000d7; 0.78 &#x000d7; 0.78 mm<sup>3</sup> to optimize segmentation performance. Next, the image intensities were clipped to the range of 0.5% to 99.5% to reduce outliers. Finally, Z score normalization was applied to standardize the intensities to zero mean and unit variance, ensuring compatibility with the model. To enhance the model&#x02019;s generalization ability, various data augmentation strategies, including rotation, scaling, and random cropping, were applied during training. The model was trained using a combination of Dice loss and cross-entropy loss functions, with a batch size of 2. The initial learning rate was set to 0.01, and the Adam optimizer was used, with a stochastic gradient descent strategy and a Nesterov momentum of 0.99. The model was trained for a total of 1000 epochs without employing an early stopping strategy. The entire training and inference process was implemented using the PyTorch framework on a Windows operating system with an NVIDIA 4090 RTX GPU.</p></sec><sec id="Sec8"><title>Radiomics feature extraction</title><p id="Par35">Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> illustrates the workflow of the radiomic study. The nnU-Net model was used to automatically segment the CT images of the portal venous phase, obtaining a three-dimensional region of interest (3D-ROI) for each patient. To ensure consistency, the segmented images and corresponding original CT images were resampled to a fixed voxel size of 1.0&#x02009;&#x000d7;&#x02009;1.0&#x02009;&#x000d7;&#x02009;1.0&#x02009;mm&#x000b3; using SimpleITK (version 2.1.1; <ext-link ext-link-type="uri" xlink:href="https://simpleitk.org">https://simpleitk.org</ext-link>). The gray-level intensity values of the resampled images were normalized using <italic>Z</italic> score normalization [<xref ref-type="bibr" rid="CR23">23</xref>] to minimize variability across datasets.<fig id="Fig3"><label>Fig. 3</label><caption><p>The radiomics diagram of the study</p></caption><graphic xlink:href="13244_2025_1923_Fig3_HTML" id="d33e512"/></fig></p><p id="Par36">Radiomic features were extracted from each 3D-ROI using PyRadiomics software [<xref ref-type="bibr" rid="CR24">24</xref>] (version 3.0.1; <ext-link ext-link-type="uri" xlink:href="https://pypi.org/project/pyradiomics/">https://pypi.org/project/pyradiomics/</ext-link>). The feature extraction process adhered to the guidelines of the Imaging Biomarker Standardization Initiative (IBSI) [<xref ref-type="bibr" rid="CR25">25</xref>]. A total of 1874 radiomic features were extracted for each patient, including first-order features (360), a gray-level cooccurrence matrix (GLCM, 480), a gray-level dependence matrix (GLDM, 280), a gray-level run length matrix (GLRLM, 320), a gray-level size zone matrix (GLSZM, 320), a neighboring gray-tone difference matrix (NGTDM, 100), and shape-based features (14).</p></sec><sec id="Sec9"><title>Radiomics feature selection and model building</title><p id="Par37">Feature selection was performed on the training set. First, collinear features with Pearson correlation coefficients (absolute values) &#x02265;&#x02009;0.9 were eliminated. Then, features with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 were retained using SelectKBest. Finally, the least absolute shrinkage and selection operator (LASSO) regression algorithm was used to select the optimal features by adjusting the penalty parameter <italic>&#x003bb;</italic>, and the radiomics score (Radscore) was calculated based on the LASSO coefficients. A logistic regression (LR) classifier was used to construct the radiomic model. Univariate and multivariate LR analyses were conducted on the clinical and radiological features to identify independent predictors of the Lauren classification and construct a clinical model. The combined clinical-radiomics model was built by integrating the independent predictors and the Radscore.</p></sec><sec id="Sec10"><title>Statistical analysis</title><p id="Par38">Normally distributed continuous variables are expressed as the means&#x02009;&#x000b1;&#x02009;standard deviations and were compared using the independent samples <italic>t</italic>-test. Nonnormally distributed data are presented as medians (interquartile ranges, M [P25, P75]) and were compared using the Mann&#x02012;Whitney <italic>U</italic>-test for two groups or the Kruskal&#x02012;Wallis <italic>H</italic>-test for multiple groups. Categorical variables are expressed as frequencies (percentages) and were compared using the <italic>&#x003c7;</italic>&#x000b2; test or Fisher&#x02019;s exact test. Univariate and multivariate LR analyses were conducted to identify independent predictors. The accuracy of the automatic segmentation model was quantified using the DSC. Model performance was evaluated by plotting receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The DeLong test was used to compare the performance of different models. Statistical analyses were performed using SPSS (version 27.0) and R software (version 3.5.3). A two-sided <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><sec id="Sec12"><title>Baseline characteristics of patients</title><p id="Par39">Among the 592 patients who underwent gastrectomy for GC, 26 were excluded because of preoperative antitumor treatment, 29 because of poor image quality, 7 because of a maximum tumor diameter &#x0003c;&#x02009;1&#x02009;cm, and 96 because of mixed-type Lauren classification (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). A total of 433 GC patients with an age range of 26-90 years (median age 69 years (IQR, 59&#x02013;72.5 years)), of whom 322 were male (74.4%) and 111 were female (25.6%), were included in this study. The histological results revealed that the Lauren classification included 228 cases of the intestinal type (52.7%) and 205 cases of the diffuse type (47.3%). The distribution of the Lauren classification was balanced across the training, internal validation, and external test sets 1 and 2 (<italic>p</italic>&#x02009;=&#x02009;0.649), indicating that there was no significant difference in classification distribution between the different datasets. This enhances the reliability of model training and validation, ensuring the generalizability and robustness of the study results. All baseline characteristics are detailed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics of patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>Training set (<italic>n</italic>&#x02009;=&#x02009;219)</th><th>Internal validation set (<italic>n</italic>&#x02009;=&#x02009;95)</th><th>External test set-1 (<italic>n</italic>&#x02009;=&#x02009;69)</th><th>External test set-2 (<italic>n</italic>&#x02009;=&#x02009;50)</th><th><italic>p-</italic>value</th></tr></thead><tbody><tr><td>Age (years), median (IQR)</td><td>68.0 (60.0, 74.0)</td><td>65.0 (58.0, 72.0)</td><td>64.0 (53.5, 69.0)</td><td>70.0 (60.8, 72.3)</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Gender, no. (%)</td><td/><td/><td/><td/><td>0.971</td></tr><tr><td>&#x02003;Female</td><td>55 (25.1)</td><td>25 (26.3)</td><td>17 (24.6)</td><td>14 (28.0)</td><td/></tr><tr><td>&#x02003;Male</td><td>164 (74.9)</td><td>70 (73.7)</td><td>52 (75.4)</td><td>36 (72.0)</td><td/></tr><tr><td>Smoking history, no. (%)</td><td/><td/><td/><td/><td>0.724</td></tr><tr><td>&#x02003;Nonsmoker</td><td>166 (75.8)</td><td>67 (70.5)</td><td>52 (75.4)</td><td>39 (78.0)</td><td/></tr><tr><td>&#x02003;Smoker</td><td>53 (24.2)</td><td>28 (29.5)</td><td>17 (24.6)</td><td>11 (22.0)</td><td/></tr><tr><td>Drinking history, no. (%)</td><td/><td/><td/><td/><td>0.904</td></tr><tr><td>&#x02003;Non-drinker</td><td>172 (78.5)</td><td>73 (76.8)</td><td>55 (79.7)</td><td>41 (82.0)</td><td/></tr><tr><td>&#x02003;Drinker</td><td>47 (21.5)</td><td>22 (23.2)</td><td>14 (20.3)</td><td>9 (18.0)</td><td/></tr><tr><td>Hypertension, no. (%)</td><td/><td/><td/><td/><td>0.315</td></tr><tr><td>&#x02003;Yes</td><td>72 (32.9)</td><td>27 (28.4)</td><td>19 (27.5)</td><td>10 (20.0)</td><td/></tr><tr><td>&#x02003;No</td><td>147 (67.1)</td><td>68 (71.6)</td><td>50 (72.5)</td><td>40 (80.0)</td><td/></tr><tr><td>Diabetes, no. (%)</td><td/><td/><td/><td/><td>0.256</td></tr><tr><td>&#x02003;Yes</td><td>27 (12.3)</td><td>8 (8.4)</td><td>3 (4.3)</td><td>5 (10.0)</td><td/></tr><tr><td>&#x02003;No</td><td>192 (87.7)</td><td>87 (91.6)</td><td>66 (95.7)</td><td>45 (90.0)</td><td/></tr><tr><td>CEA (ng/mL), median (IQR)</td><td>2.52 (1.46, 4.88)</td><td>2.24 (1.21, 4.41)</td><td>2.52 (1.59, 4.01)</td><td>2.57 (1.26, 3.86)</td><td>0.612</td></tr><tr><td>CA125 (U/mL), median (IQR)</td><td>9.83 (6.59, 14.82)</td><td>9.25 (6.84, 14.21)</td><td>7.53 (5.49, 11.09)</td><td>8.95 (6.17, 11.48)</td><td>0.024</td></tr><tr><td>CA19-9 (U/mL), median (IQR)</td><td>11.59 (5.97, 30.16)</td><td>10.57 (6.63, 28.44)</td><td>8.60 (4.35, 16.08)</td><td>10.60 (6.11, 18.05)</td><td>0.152</td></tr><tr><td>Maximum tumor diameter (cm), median (IQR)</td><td>4.80 (3.50, 6.50)</td><td>5.20 (4.00, 6.50)</td><td>5.00 (3.50, 7.50)</td><td>5.75 (4.45, 8.00)</td><td>0.031</td></tr><tr><td>Lauren type, no. (%)</td><td/><td/><td/><td/><td>0.649</td></tr><tr><td>&#x02003;Intestinal type</td><td>119 (54.3)</td><td>52 (54.7)</td><td>32 (46.4)</td><td>25 (50.0)</td><td/></tr><tr><td>&#x02003;Diffuse type</td><td>100 (45.7)</td><td>43 (45.3)</td><td>37 (53.6)</td><td>25 (50.0)</td><td/></tr></tbody></table><table-wrap-foot><p><italic>IQR</italic> interquartile range, <italic>CEA</italic> carcinoma embryonic antigen, <italic>CA125</italic> cancer antigen 125, <italic>CA19-9</italic> cancer antigen 19-9</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec13"><title>Performance evaluation of the nnU-Net automatic segmentation model</title><p id="Par40">The performance of the automatic segmentation model was evaluated through 5-fold cross-validation in the training and validation sets. The best segmentation results for the DSC, IoU, precision, and recall metrics were 80.99%, 68.22%, 85.77%, and 76.80%, respectively. For the test set, the DSC, IoU, precision, and recall values were 79.79%, 66.59%, 84.91%, and 73.89%, respectively (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref> shows comparison examples of manual and automatic segmentation of lesions in GC patients.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Fivefold cross-validation and test set results of the automatic segmentation model</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Performance metric</th><th>Fold 0</th><th>Fold 1</th><th>Fold 2</th><th>Fold 3</th><th>Fold 4</th><th>Test Set</th></tr></thead><tbody><tr><td>DSC (%)</td><td>77.19</td><td>75.27</td><td>80.99</td><td>80.14</td><td>75.80</td><td>79.79</td></tr><tr><td>IoU (%)</td><td>63.11</td><td>61.94</td><td>68.22</td><td>67.06</td><td>61.38</td><td>66.59</td></tr><tr><td>Precision (%)</td><td>79.48</td><td>84.54</td><td>85.77</td><td>85.88</td><td>77.85</td><td>84.91</td></tr><tr><td>Recall (%)</td><td>74.45</td><td>66.40</td><td>76.80</td><td>73.26</td><td>70.49</td><td>73.89</td></tr></tbody></table><table-wrap-foot><p><italic>DSC</italic> dice similarity coefficient, <italic>IoU</italic> intersection over union</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>Results of clinical feature selection and model evaluation</title><p id="Par41">Univariate analysis of the training set revealed that age, CA125 level, and maximum tumor diameter were associated with the Lauren classification (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). Multivariate logistic regression analysis further indicated that age (OR&#x02009;=&#x02009;0.95; 95% CI [0.92, 0.98]; <italic>p</italic>&#x02009;=&#x02009;0.003), CA125 level (OR&#x02009;=&#x02009;1.05; 95% CI [1.01, 1.10]; <italic>p</italic>&#x02009;=&#x02009;0.015), and maximum tumor diameter (OR&#x02009;=&#x02009;1.27; 95% CI [1.11, 1.46]; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) were independent predictors of the Lauren classification (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). A clinical model was constructed based on these independent predictors. The ROC curve of this model showed AUC values of 0.70 (95% CI, 0.62&#x02013;0.76), 0.67 (95% CI, 0.55&#x02013;0.77), 0.65 (95% CI, 0.52&#x02013;0.78), and 0.73 (95% CI, 0.59&#x02013;0.86) in the training set, internal validation set, external test set-1, and external test set-2, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Results of univariate and multivariate logistic regression analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="2">Univariable analysis</th><th colspan="2">Multivariable analysis</th></tr><tr><th>OR</th><th><italic>p</italic>-value</th><th>OR</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td>Age (years)</td><td>0.96 (0.94, 0.99)</td><td>0.017</td><td>0.95 (0.92, 0.98)</td><td>0.004</td></tr><tr><td>Gender (female vs. male)</td><td>0.68 (0.37, 1.26)</td><td>0.225</td><td>NA</td><td>NA</td></tr><tr><td>Smoking history (absent vs. present)</td><td>1.08 (0.58, 2.01)</td><td>0.800</td><td>NA</td><td>NA</td></tr><tr><td>Drinking history (absent vs. present)</td><td>0.95 (0.50, 1.82)</td><td>0.879</td><td>NA</td><td>NA</td></tr><tr><td>Hypertension (yes vs. no)</td><td>0.79 (0.45, 1.39)</td><td>0.407</td><td>NA</td><td>NA</td></tr><tr><td>Diabetes (yes vs. no)</td><td>0.80 (0.35, 1.80)</td><td>0.584</td><td>NA</td><td>NA</td></tr><tr><td>CEA (ng/mL)</td><td>1.00 (0.99, 1.01)</td><td>0.875</td><td>NA</td><td>NA</td></tr><tr><td>CA125 (U/mL)</td><td>1.05 (1.01, 1.09)</td><td>0.011</td><td>1.05 (1.01, 1.10)</td><td>0.018</td></tr><tr><td>CA19-9 (U/mL)</td><td>1.00 (1.00,1.00)</td><td>0.369</td><td>NA</td><td>NA</td></tr><tr><td>Maximum tumor diameter (cm)</td><td>1.26 (1.12,1.43)</td><td>&#x0003c;&#x02009;0.001</td><td>1.25 (1.10, 1.43)</td><td>&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Data in parentheses are 95% CI</p><p><italic>CEA</italic> carcinoma embryonic antigen, <italic>CA125</italic> cancer antigen 125, <italic>CA19-9</italic> cancer antigen 19-9, <italic>NA</italic> not applicable, <italic>OR</italic> odds ratio</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>Comparison of ROC curves for different models. <bold>A</bold> Training set; <bold>B</bold> Internal validation set; <bold>C</bold> External test set-1; <bold>D</bold> External test set-2. The legend shows the AUC values and 95% confidence intervals (CI). The green, red, and blue lines represent the clinical model, radiomics model, and combined model, respectively</p></caption><graphic xlink:href="13244_2025_1923_Fig4_HTML" id="d33e1207"/></fig></p></sec><sec id="Sec15"><title>Results of radiomics feature selection and model evaluation</title><p id="Par42">During feature selection, Pearson correlation analysis initially revealed 347 features. The SelectKBest function further reduced this number to 134 features. Finally, the LASSO regression algorithm selected 7 optimal features (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). These features were used to calculate the Radscore, and a radiomic model was constructed using the LR classifier. The ROC curve for this model showed AUC values of 0.86 (95% CI, 0.81&#x02013;0.91), 0.84 (95% CI, 0.75&#x02013;0.93), 0.83 (95% CI, 0.71&#x02013;0.93), and 0.81 (95% CI, 0.68&#x02013;0.93) in the training set, internal validation set, external test set-1, and external test set-2, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). A visual nomogram was developed on the basis of the training set (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The calibration curves and decision curves are shown in Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref> and <xref rid="MOESM1" ref-type="media">4</xref>.<fig id="Fig5"><label>Fig. 5</label><caption><p>Nomogram developed from the training set for preoperative prediction of -GC the Lauren classification: <bold>A</bold> Clinical model, <bold>B</bold> Radiomics model, and <bold>C</bold> Combined model</p></caption><graphic xlink:href="13244_2025_1923_Fig5_HTML" id="d33e1244"/></fig></p></sec><sec id="Sec16"><title>Evaluation of the combined clinical-radiomics model</title><p id="Par43">A combined clinical&#x02012;radiomics model was constructed based on age, CA125 level, maximum tumor diameter, and the radiomics Radscore. The ROC curve for this model showed AUC values of 0.87 (95% CI, 0.82&#x02013;0.92), 0.81 (95% CI, 0.71&#x02013;0.89), 0.81 (95% CI, 0.7&#x02013;0.91), and 0.82 (95% CI, 0.69&#x02013;0.93) in the training set, internal validation set, external test set-1, and external test set-2, respectively (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p></sec><sec id="Sec17"><title>Comparison of the performance of clinical, radiomics, and combined models</title><p id="Par44">The AUCs of the clinical, radiomic, and combined models were compared using the DeLong test. The results revealed that in the training set, internal validation set, and external test set-1, the AUCs of the radiomic and combined models were significantly greater than those of the clinical model (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). However, there was no significant difference in AUC performance between the radiomic and combined models (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). In the external test set-2, there was no significant difference in AUC performance among the clinical, radiomics, and combined models (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). In summary, the radiomic and combined models generally outperformed the clinical model in terms of AUC performance, but there was no significant difference between the radiomic and combined models.</p></sec></sec><sec id="Sec18" sec-type="discussion"><title>Discussion</title><p id="Par45">Preoperative prediction of the Lauren classification in patients with GC helps improve the specificity and effectiveness of treatment. The main findings of our study included the following: (1) efficient automatic segmentation of GC lesions could be achieved using the nnU-Net model; (2) preoperative identification of the Lauren classification in GC using a radiomic model could be achieved with high accuracy; and (3) the radiomic model for Lauren classification in GC had strong generalizability in a multicenter study.</p><p id="Par46">The Lauren classification is an important prognostic factor for GC [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. The preoperative classification relies primarily on histopathological results from an endoscopic biopsy. However, the limited sample size and uncertainty in sampling locations lead to a consistency rate of only 64.7&#x02013;75% between biopsy and surgical samples, increasing the risk of misclassification [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Studies indicate that intestinal-type GC generally has a better response to surgery and chemotherapy, whereas diffuse-type GC is more aggressive and has a poorer prognosis [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Therefore, accurately predicting the Lauren classification preoperatively is crucial for clinicians to formulate individualized treatment plans and assess patient prognosis. In this study, we used a combination of nnU-Net and radiomics for noninvasive preoperative classification, with a focus on predicting the intestinal and diffuse types of GC. Given the similar survival outcomes between mixed-type and diffuse-type GC (45.6% vs. 43.4%) [<xref ref-type="bibr" rid="CR27">27</xref>] and the complex biological characteristics of mixed-type GC, we chose to exclude it to enhance the model&#x02019;s predictive performance.</p><p id="Par47">To improve the efficiency and quality of radiomics research, this study developed an automatic segmentation model for GC lesions based on nnU-Net, achieving mean DSCs of 0.81 and 0.79 in the validation and test sets, respectively, indicating high efficiency and accuracy in segmenting GC tumor regions. Ferrante et al [<xref ref-type="bibr" rid="CR32">32</xref>] applied a nnU-Net-based framework for automatic lung tumor segmentation on CT images, achieving a mean DSC of 0.78&#x02009;&#x000b1;&#x02009;0.12. Jeon et al [<xref ref-type="bibr" rid="CR33">33</xref>] developed a fully automated multiorgan segmentation tool for both plain and enhanced abdominal CT scans using a deep learning algorithm based on nnU-Net, with mean DSCs exceeding 0.94 for the liver, spleen, right kidney and left kidney. In contrast, Gao et al [<xref ref-type="bibr" rid="CR34">34</xref>] developed a nnU-Net-based automatic segmentation model to segment lesions in patients with Crohn&#x02019;s disease (CD), achieving a mean DSC of 0.824 in the test set. Additional studies [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>] have confirmed the high performance of automatic segmentation models. Collectively, these studies demonstrate that nnU-Net performs well in the automatic segmentation of both tumorous and inflammatory lesions, providing strong support for the present study.</p><p id="Par48">Radiomics was first proposed by Lambin et al [<xref ref-type="bibr" rid="CR9">9</xref>] and later applied by Aerts et al [<xref ref-type="bibr" rid="CR10">10</xref>] to the analysis of CT imaging data for predicting tumor gene expression patterns and patient outcomes. In this study, we developed a radiomics model based on nnU-Net automatic segmentation to predict the Lauren classification of GC preoperatively. The results demonstrated that automatic segmentation has significant advantages in achieving efficient and accurate 3D-ROI segmentation of GC lesions [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. The AUC values of our clinical model, radiomics model, and combined model ranged from 0.65 to 0.73, 0.81 to 0.86, and 0.81 to 0.87, respectively, across different datasets. Delong tests indicated that the AUC performance of the radiomic and combined models was superior to that of the clinical model, with no significant difference between the radiomic and combined models. These findings suggest that radiomic features may already contain primary predictive information and that the addition of clinical features did not significantly enhance the performance of the combined model. Previous studies [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>] have also reported the strong performance of radiomic models in predicting the Lauren classification of GC, which is consistent with the findings of our study. For example, Nie et al [<xref ref-type="bibr" rid="CR40">40</xref>] reported AUC values of 0.832 and 0.760 for venous-phase radiomic models in the training and test cohorts, respectively, with their combined model achieving AUCs of 0.849 and 0.793, respectively. Similarly, Li et al [<xref ref-type="bibr" rid="CR41">41</xref>] reported AUCs of 0.855 and 0.802 for their combined radiomics model in the training and testing sets, respectively.</p><p id="Par49">Unlike previous single-center studies [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>], our study adopted a multicenter research design, providing stronger generalizability and broader applicability of the results. Multicenter studies can offer more diverse data sources, reducing sample bias and enhancing the reliability and external validity of the research results. However, multicenter studies also face challenges in coordinating and standardizing data collection and processing, requiring rigorous study design and management to ensure data consistency and comparability.</p><p id="Par50">This study has several limitations. First, as a retrospective study, data collection and analysis may have biases. Second, although we introduced multicenter data for external testing, the sample size was relatively small. Future studies with larger-scale prospective research are needed to further validate the results. Third, our study only used CT imaging data; future research could combine other imaging modalities (such as MRI and PET) to further optimize and validate the model. Additionally, integrating more molecular characteristics, such as gene expression and proteomics data, could lead to the construction of multilayered, multidisciplinary comprehensive prediction models.</p><p id="Par51">In conclusion, our study successfully developed a preoperative Lauren classification prediction model for GC based on nnU-Net automatic segmentation and radiomics technology. Through multicenter data validation, the model demonstrated high predictive performance, aiding clinicians in the early identification of GC classification and formulation of appropriate treatment plans to achieve precision and personalized medicine.</p></sec><sec id="Sec19" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13244_2025_1923_MOESM1_ESM.pdf"><caption><p>ELECTRONIC SUPPLEMENTARY MATERIAL</p></caption></media></supplementary-material>
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AUC</term><def><p id="Par11">Area under the curve</p></def></def-item><def-item><term>CA125</term><def><p id="Par12">Cancer antigen 125</p></def></def-item><def-item><term>CA19-9</term><def><p id="Par13">Carbohydrate antigen 19-9</p></def></def-item><def-item><term>CEA</term><def><p id="Par14">Carcinoembryonic antigen</p></def></def-item><def-item><term>CT</term><def><p id="Par15">Computed tomography</p></def></def-item><def-item><term>DSC</term><def><p id="Par16">Dice similarity coefficient</p></def></def-item><def-item><term>GC</term><def><p id="Par17">Gastric cancer</p></def></def-item><def-item><term>IoU</term><def><p id="Par18">Intersection over union</p></def></def-item><def-item><term>LASSO</term><def><p id="Par19">The least absolute shrinkage and selection operator</p></def></def-item><def-item><term>Radscore</term><def><p id="Par20">Radiomics score</p></def></def-item><def-item><term>ROC</term><def><p id="Par21">Receiver operating characteristic</p></def></def-item><def-item><term>ROI</term><def><p id="Par22">Region of interest</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Bo Cao, Jun Hu, Haige Li, Xuebing Liu and Chang Rong contributed equally to this work.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1186/s13244-025-01923-9.</p></sec><notes notes-type="author-contribution"><title>Author contributions</title><p>Cao B., Hu J., and Liu X.B. were responsible for data collection and analysis and were the main contributors to writing the manuscript. Rong C. provided technical support, including data for automatic segmentation. Li S. assisted with the literature search and participated in data analysis. He X. was responsible for the interpretation of pathological data. Zheng X.M. and Liu K.C. critically revised the manuscript. Wang C.B. and Guo W. contributed to the conception of the study. Wu X.W. and Li H.G. were responsible for the overall design and direction of the study. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This&#x000a0;study was supported by the Natural Science Foundation of Anhui Province, China (Grant No. 2308085MH241).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data supporting the findings of this study are available from the corresponding author upon reasonable request. Due to privacy or ethical restrictions, the data cannot be publicly shared.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par52">This study was approved by the Institutional Review Boards (IRBs) of the First Affiliated Hospital of Anhui Medical University, the First Affiliated Hospital of the University of Science and Technology of China, and the Second Affiliated Hospital of Nanjing Medical University. Informed consent was waived due to the retrospective nature of this study.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par53">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par54">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title><source>CA Cancer J CLIN</source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><pub-id pub-id-type="pmid">33538338</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J CLIN 71:209&#x02013;249.&#x000a0;10.3322/caac.21660<pub-id pub-id-type="pmid">33538338</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Lauren</surname><given-names>P</given-names></name></person-group><article-title>The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma</article-title><source>Acta Pathol Microbiol Scand</source><year>1965</year><volume>64</volume><fpage>31</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1111/apm.1965.64.1.31</pub-id><pub-id pub-id-type="pmid">14320675</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31&#x02013;49. 10.1111/apm.1965.64.1.31<pub-id pub-id-type="pmid">14320675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez Fonseca</surname><given-names>P</given-names></name><name><surname>Carmona-Bayonas</surname><given-names>A</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>R</given-names></name><etal/></person-group><article-title>Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry</article-title><source>Br J Cancer</source><year>2017</year><volume>117</volume><fpage>775</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/bjc.2017.245</pub-id><pub-id pub-id-type="pmid">28765618</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Jim&#x000e9;nez Fonseca P, Carmona-Bayonas A, Hern&#x000e1;ndez R et al (2017) Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. Br J Cancer 117:775&#x02013;782. 10.1038/bjc.2017.245<pub-id pub-id-type="pmid">28765618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Chang</surname><given-names>KK</given-names></name><name><surname>Yoon</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>LH</given-names></name><name><surname>Strong</surname><given-names>VE</given-names></name><name><surname>Yoon</surname><given-names>SS</given-names></name></person-group><article-title>Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma</article-title><source>Ann Surg</source><year>2018</year><volume>267</volume><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000002040</pub-id><pub-id pub-id-type="pmid">27759618</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS (2018) Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg 267:105&#x02013;113. 10.1097/SLA.0000000000002040<pub-id pub-id-type="pmid">27759618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Thrift</surname><given-names>AP</given-names></name><name><surname>Wenker</surname><given-names>TN</given-names></name><name><surname>El-Serag</surname><given-names>HB</given-names></name></person-group><article-title>Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention</article-title><source>Nat Rev Clin Oncol</source><year>2023</year><volume>20</volume><fpage>338</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/s41571-023-00747-0</pub-id><pub-id pub-id-type="pmid">36959359</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Thrift AP, Wenker TN, El-Serag HB (2023) Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol 20:338&#x02013;349. 10.1038/s41571-023-00747-0<pub-id pub-id-type="pmid">36959359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Lordick</surname><given-names>F</given-names></name><name><surname>Carneiro</surname><given-names>F</given-names></name><name><surname>Cascinu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up</article-title><source>Ann Oncol</source><year>2022</year><volume>33</volume><fpage>1005</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1016/j.annonc.2022.07.004</pub-id><pub-id pub-id-type="pmid">35914639</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Lordick F, Carneiro F, Cascinu S et al (2022) Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33:1005&#x02013;1020. 10.1016/j.annonc.2022.07.004<pub-id pub-id-type="pmid">35914639</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Oue</surname><given-names>N</given-names></name><name><surname>Sentani</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>N</given-names></name><name><surname>Uraoka</surname><given-names>N</given-names></name><name><surname>Yasui</surname><given-names>W</given-names></name></person-group><article-title>Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells</article-title><source>Int J Clin Oncol</source><year>2019</year><volume>24</volume><fpage>771</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1007/s10147-019-01443-9</pub-id><pub-id pub-id-type="pmid">30980196</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W (2019) Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol 24:771&#x02013;778. 10.1007/s10147-019-01443-9<pub-id pub-id-type="pmid">30980196</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;cken</surname><given-names>C</given-names></name></person-group><article-title>Predictive biomarkers in gastric cancer</article-title><source>J Cancer Res Clin Oncol</source><year>2023</year><volume>149</volume><fpage>467</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1007/s00432-022-04408-0</pub-id><pub-id pub-id-type="pmid">36260159</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">R&#x000f6;cken C (2023) Predictive biomarkers in gastric cancer. J Cancer Res Clin Oncol 149:467&#x02013;481. 10.1007/s00432-022-04408-0<pub-id pub-id-type="pmid">36260159</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Lambin</surname><given-names>P</given-names></name><name><surname>Rios-Velazquez</surname><given-names>E</given-names></name><name><surname>Leijenaar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Radiomics: extracting more information from medical images using advanced feature analysis</article-title><source>Eur J Cancer</source><year>2012</year><volume>48</volume><fpage>441</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2011.11.036</pub-id><pub-id pub-id-type="pmid">22257792</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441&#x02013;446. 10.1016/j.ejca.2011.11.036<pub-id pub-id-type="pmid">22257792</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Aerts</surname><given-names>HJ</given-names></name><name><surname>Velazquez</surname><given-names>ER</given-names></name><name><surname>Leijenaar</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>4006</fpage><pub-id pub-id-type="doi">10.1038/ncomms5006</pub-id><pub-id pub-id-type="pmid">24892406</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. 10.1038/ncomms5006<pub-id pub-id-type="pmid">24892406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Gillies</surname><given-names>RJ</given-names></name><name><surname>Kinahan</surname><given-names>PE</given-names></name><name><surname>Hricak</surname><given-names>H</given-names></name></person-group><article-title>Radiomics: images are more than pictures, they are data</article-title><source>Radiology</source><year>2016</year><volume>278</volume><fpage>563</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1148/radiol.2015151169</pub-id><pub-id pub-id-type="pmid">26579733</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563&#x02013;577.&#x000a0;10.1148/radiol.2015151169<pub-id pub-id-type="pmid">26579733</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Lambin</surname><given-names>P</given-names></name><name><surname>Leijenaar</surname><given-names>R</given-names></name><name><surname>Deist</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Radiomics: the bridge between medical imaging and personalized medicine</article-title><source>Nat Rev Clin Oncol</source><year>2017</year><volume>14</volume><fpage>749</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2017.141</pub-id><pub-id pub-id-type="pmid">28975929</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Lambin P, Leijenaar R, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749&#x02013;762. 10.1038/nrclinonc.2017.141<pub-id pub-id-type="pmid">28975929</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>KY</given-names></name><name><surname>Hu</surname><given-names>HT</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><etal/></person-group><article-title>CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer</article-title><source>BMC Cancer</source><year>2020</year><volume>20</volume><fpage>468</fpage><pub-id pub-id-type="doi">10.1186/s12885-020-06970-7</pub-id><pub-id pub-id-type="pmid">32450841</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Sun KY, Hu HT, Chen SL et al (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20:468. 10.1186/s12885-020-06970-7<pub-id pub-id-type="pmid">32450841</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Noninvasive prediction of occult peritoneal metastasis in gastric cancer using deep learning</article-title><source>JAMA Netw Open</source><year>2021</year><volume>4</volume><fpage>e2032269</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.32269</pub-id><pub-id pub-id-type="pmid">33399858</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Jiang Y, Liang X, Wang W et al (2021) Noninvasive prediction of occult peritoneal metastasis in gastric cancer using deep learning. JAMA Netw Open 4:e2032269.&#x000a0;10.1001/jamanetworkopen.2020.32269<pub-id pub-id-type="pmid">33399858</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study</article-title><source>Lancet Digit Health</source><year>2022</year><volume>4</volume><fpage>e340</fpage><lpage>e350</lpage><pub-id pub-id-type="doi">10.1016/S2589-7500(22)00040-1</pub-id><pub-id pub-id-type="pmid">35461691</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Jiang Y, Zhang Z, Yuan Q et al (2022) Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. Lancet Digit Health 4:e340&#x02013;e350. 10.1016/S2589-7500(22)00040-1<pub-id pub-id-type="pmid">35461691</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>van Timmeren</surname><given-names>JE</given-names></name><name><surname>Cester</surname><given-names>D</given-names></name><name><surname>Tanadini-Lang</surname><given-names>S</given-names></name><name><surname>Alkadhi</surname><given-names>H</given-names></name><name><surname>Baessler</surname><given-names>B</given-names></name></person-group><article-title>Radiomics in medical imaging-&#x0201c;how-to&#x0201d; guide and critical reflection</article-title><source>Insights Imaging</source><year>2020</year><volume>11</volume><fpage>91</fpage><pub-id pub-id-type="doi">10.1186/s13244-020-00887-2</pub-id><pub-id pub-id-type="pmid">32785796</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B (2020) Radiomics in medical imaging-&#x0201c;how-to&#x0201d; guide and critical reflection. Insights Imaging 11:91. 10.1186/s13244-020-00887-2<pub-id pub-id-type="pmid">32785796</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Isensee</surname><given-names>F</given-names></name><name><surname>Jaeger</surname><given-names>PF</given-names></name><name><surname>Kohl</surname><given-names>S</given-names></name><name><surname>Petersen</surname><given-names>J</given-names></name><name><surname>Maier-Hein</surname><given-names>KH</given-names></name></person-group><article-title>nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation</article-title><source>Nat Methods</source><year>2021</year><volume>18</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-01008-z</pub-id><pub-id pub-id-type="pmid">33288961</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Isensee F, Jaeger PF, Kohl S, Petersen J, Maier-Hein KH (2021) nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods 18:203&#x02013;211. 10.1038/s41592-020-01008-z<pub-id pub-id-type="pmid">33288961</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Pyo</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Min</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis</article-title><source>J Gastroenterol</source><year>2017</year><volume>52</volume><fpage>594</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1007/s00535-016-1254-5</pub-id><pub-id pub-id-type="pmid">27590416</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Pyo JH, Lee H, Min BH et al (2017) Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis. J Gastroenterol 52:594&#x02013;601. 10.1007/s00535-016-1254-5<pub-id pub-id-type="pmid">27590416</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><etal/></person-group><article-title>Relationship between histological mixed-type early gastric cancer and lymph node metastasis: a systematic review and meta-analysis</article-title><source>PLoS One</source><year>2022</year><volume>17</volume><fpage>e0266952</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0266952</pub-id><pub-id pub-id-type="pmid">35427370</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Yang S, Gu X, Tao R et al (2022) Relationship between histological mixed-type early gastric cancer and lymph node metastasis: a systematic review and meta-analysis. PLoS One 17:e0266952. 10.1371/journal.pone.0266952<pub-id pub-id-type="pmid">35427370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Radiomics: the process and the challenges</article-title><source>Magn Reson Imaging</source><year>2012</year><volume>30</volume><fpage>1234</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2012.06.010</pub-id><pub-id pub-id-type="pmid">22898692</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Kumar V, Gu Y, Basu S et al (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234&#x02013;1248. 10.1016/j.mri.2012.06.010<pub-id pub-id-type="pmid">22898692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenhauer</surname><given-names>EA</given-names></name><name><surname>Therasse</surname><given-names>P</given-names></name><name><surname>Bogaerts</surname><given-names>J</given-names></name><etal/></person-group><article-title>New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)</article-title><source>Eur J Cancer</source><year>2009</year><volume>45</volume><fpage>228</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2008.10.026</pub-id><pub-id pub-id-type="pmid">19097774</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228&#x02013;247. 10.1016/j.ejca.2008.10.026<pub-id pub-id-type="pmid">19097774</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Yushkevich</surname><given-names>PA</given-names></name><name><surname>Piven</surname><given-names>J</given-names></name><name><surname>Hazlett</surname><given-names>HC</given-names></name><etal/></person-group><article-title>User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability</article-title><source>Neuroimage</source><year>2006</year><volume>31</volume><fpage>1116</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.01.015</pub-id><pub-id pub-id-type="pmid">16545965</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yushkevich PA, Piven J, Hazlett HC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116&#x02013;1128. 10.1016/j.neuroimage.2006.01.015<pub-id pub-id-type="pmid">16545965</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Avanzo</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Stancanello</surname><given-names>J</given-names></name><etal/></person-group><article-title>Machine and deep learning methods for radiomics</article-title><source>Med Phys</source><year>2020</year><volume>47</volume><fpage>e185</fpage><lpage>e202</lpage><pub-id pub-id-type="doi">10.1002/mp.13678</pub-id><pub-id pub-id-type="pmid">32418336</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Avanzo M, Wei L, Stancanello J et al (2020) Machine and deep learning methods for radiomics. Med Phys 47:e185&#x02013;e202. 10.1002/mp.13678<pub-id pub-id-type="pmid">32418336</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>van Griethuysen</surname><given-names>J</given-names></name><name><surname>Fedorov</surname><given-names>A</given-names></name><name><surname>Parmar</surname><given-names>C</given-names></name><etal/></person-group><article-title>Computational radiomics system to decode the radiographic phenotype</article-title><source>Cancer Res</source><year>2017</year><volume>77</volume><fpage>e104</fpage><lpage>e107</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0339</pub-id><pub-id pub-id-type="pmid">29092951</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">van Griethuysen J, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104&#x02013;e107. 10.1158/0008-5472.CAN-17-0339<pub-id pub-id-type="pmid">29092951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Zwanenburg</surname><given-names>A</given-names></name><name><surname>Valli&#x000e8;res</surname><given-names>M</given-names></name><name><surname>Abdalah</surname><given-names>MA</given-names></name><etal/></person-group><article-title>The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping</article-title><source>Radiology</source><year>2020</year><volume>295</volume><fpage>328</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1148/radiol.2020191145</pub-id><pub-id pub-id-type="pmid">32154773</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zwanenburg A, Valli&#x000e8;res M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328&#x02013;338. 10.1148/radiol.2020191145<pub-id pub-id-type="pmid">32154773</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients</article-title><source>BMC Cancer</source><year>2014</year><volume>14</volume><fpage>823</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-14-823</pub-id><pub-id pub-id-type="pmid">25380654</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Qiu M, Zhou Y, Zhang X et al (2014) Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer 14:823. 10.1186/1471-2407-14-823<pub-id pub-id-type="pmid">25380654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Fang</surname><given-names>WL</given-names></name><name><surname>Wang</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Clinicopathological variation of Lauren classification in gastric cancer</article-title><source>Pathol Oncol Res</source><year>2016</year><volume>22</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1007/s12253-015-9996-6</pub-id><pub-id pub-id-type="pmid">26502923</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Chen YC, Fang WL, Wang RF et al (2016) Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res 22:197&#x02013;202. 10.1007/s12253-015-9996-6<pub-id pub-id-type="pmid">26502923</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Schirren</surname><given-names>R</given-names></name><name><surname>Novotny</surname><given-names>A</given-names></name><name><surname>Slotta-Huspenina</surname><given-names>J</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Reim</surname><given-names>D</given-names></name></person-group><article-title>Novel histologic categorization based on Lauren histotypes conveys prognostic information for gastroesophageal junction cancers-analysis from a large single center cohort in Germany</article-title><source>Cancers (Basel)</source><year>2021</year><volume>13</volume><fpage>1303</fpage><pub-id pub-id-type="doi">10.3390/cancers13061303</pub-id><pub-id pub-id-type="pmid">33804009</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Schirren R, Novotny A, Slotta-Huspenina J, Friess H, Reim D (2021) Novel histologic categorization based on Lauren histotypes conveys prognostic information for gastroesophageal junction cancers-analysis from a large single center cohort in Germany. Cancers (Basel) 13:1303. 10.3390/cancers13061303<pub-id pub-id-type="pmid">33804009</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Palli</surname><given-names>D</given-names></name><name><surname>Bianchi</surname><given-names>S</given-names></name><name><surname>Cipriani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Reproducibility of histologic classification of gastric cancer</article-title><source>Br J Cancer</source><year>1991</year><volume>63</volume><fpage>765</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1038/bjc.1991.171</pub-id><pub-id pub-id-type="pmid">2039701</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Palli D, Bianchi S, Cipriani F et al (1991) Reproducibility of histologic classification of gastric cancer. Br J Cancer 63:765&#x02013;768. 10.1038/bjc.1991.171<pub-id pub-id-type="pmid">2039701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>MZ</given-names></name><name><surname>Shi</surname><given-names>SM</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of HER2 and Lauren classification between biopsy and surgical resection samples, primary and metastatic samples of gastric cancer</article-title><source>J Cancer</source><year>2017</year><volume>8</volume><fpage>3531</fpage><lpage>3537</lpage><pub-id pub-id-type="doi">10.7150/jca.19984</pub-id><pub-id pub-id-type="pmid">29151938</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Qiu MZ, Shi SM, Chen M et al (2017) Comparison of HER2 and Lauren classification between biopsy and surgical resection samples, primary and metastatic samples of gastric cancer. J Cancer 8:3531&#x02013;3537. 10.7150/jca.19984<pub-id pub-id-type="pmid">29151938</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evaluation the benefits of additional radiotherapy for gastric cancer patients after D2 resection using CT based radiomics</article-title><source>Radiol Med</source><year>2023</year><volume>128</volume><fpage>679</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1007/s11547-023-01646-1</pub-id><pub-id pub-id-type="pmid">37188857</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Zheng H, Zheng Q, Jiang M et al (2023) Evaluation the benefits of additional radiotherapy for gastric cancer patients after D2 resection using CT based radiomics. Radiol Med 128:679&#x02013;688.&#x000a0;10.1007/s11547-023-01646-1<pub-id pub-id-type="pmid">37188857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>M</given-names></name><name><surname>Rinaldi</surname><given-names>L</given-names></name><name><surname>Botta</surname><given-names>F</given-names></name><etal/></person-group><article-title>Application of nnU-Net for automatic segmentation of lung lesions on CT images and its implication for radiomic models</article-title><source>J Clin Med</source><year>2022</year><volume>11</volume><fpage>7334</fpage><pub-id pub-id-type="doi">10.3390/jcm11247334</pub-id><pub-id pub-id-type="pmid">36555950</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Ferrante M, Rinaldi L, Botta F et al (2022) Application of nnU-Net for automatic segmentation of lung lesions on CT images and its implication for radiomic models. J Clin Med 11:7334. 10.3390/jcm11247334<pub-id pub-id-type="pmid">36555950</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>SK</given-names></name><name><surname>Joo</surname><given-names>I</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Yoon</surname><given-names>SH</given-names></name></person-group><article-title>Fully-automated multi-organ segmentation tool applicable to both non-contrast and post-contrast abdominal CT: deep learning algorithm developed using dual-energy CT images</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><fpage>4378</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-55137-y</pub-id><pub-id pub-id-type="pmid">38388824</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Jeon SK, Joo I, Park J, Kim JM, Park SJ, Yoon SH (2024) Fully-automated multi-organ segmentation tool applicable to both non-contrast and post-contrast abdominal CT: deep learning algorithm developed using dual-energy CT images. Sci Rep 14:4378. 10.1038/s41598-024-55137-y<pub-id pub-id-type="pmid">38388824</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Gao Y, Zhang B, Zhao D et al (2023) Automatic segmentation and radiomics for identification and activity assessment of CTE lesions in Crohn&#x02019;s Disease. Inflamm Bowel Dis 30:1957&#x02013;1964. 10.1093/ibd/izad285</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga-Canuto</surname><given-names>D</given-names></name><name><surname>Cerd&#x000e0;-Alberich</surname><given-names>L</given-names></name><name><surname>Jim&#x000e9;nez-Pastor</surname><given-names>A</given-names></name><etal/></person-group><article-title>Independent validation of a deep learning nnU-Net tool for neuroblastoma detection and segmentation in MR images</article-title><source>Cancers (Basel)</source><year>2023</year><volume>15</volume><fpage>1622</fpage><pub-id pub-id-type="doi">10.3390/cancers15051622</pub-id><pub-id pub-id-type="pmid">36900410</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Veiga-Canuto D, Cerd&#x000e0;-Alberich L, Jim&#x000e9;nez-Pastor A et al (2023) Independent validation of a deep learning nnU-Net tool for neuroblastoma detection and segmentation in MR images. Cancers (Basel) 15:1622. 10.3390/cancers15051622<pub-id pub-id-type="pmid">36900410</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Carles M, Kuhn D, Fechter T et al (2024) Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation. Eur Radiol 34:6701&#x02013;6711. 10.1007/s00330-024-10751-2</mixed-citation></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Bang</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>J</given-names></name></person-group><article-title>Deep learning-based multimodal segmentation of oropharyngeal squamous cell carcinoma on CT and MRI using self-configuring nnU-Net</article-title><source>Eur Radiol</source><year>2024</year><volume>34</volume><fpage>5389</fpage><lpage>5400</lpage><pub-id pub-id-type="doi">10.1007/s00330-024-10585-y</pub-id><pub-id pub-id-type="pmid">38243135</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Choi Y, Bang J, Kim SY, Seo M, Jang J (2024) Deep learning-based multimodal segmentation of oropharyngeal squamous cell carcinoma on CT and MRI using self-configuring nnU-Net. Eur Radiol 34:5389&#x02013;5400. 10.1007/s00330-024-10585-y<pub-id pub-id-type="pmid">38243135</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitto</surname><given-names>S</given-names></name><name><surname>Corino</surname><given-names>V</given-names></name><name><surname>Annovazzi</surname><given-names>A</given-names></name><etal/></person-group><article-title>3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction</article-title><source>Front Oncol</source><year>2022</year><volume>12</volume><fpage>1016123</fpage><pub-id pub-id-type="doi">10.3389/fonc.2022.1016123</pub-id><pub-id pub-id-type="pmid">36531029</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Gitto S, Corino V, Annovazzi A et al (2022) 3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction. Front Oncol 12:1016123. 10.3389/fonc.2022.1016123<pub-id pub-id-type="pmid">36531029</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Watzenboeck</surname><given-names>ML</given-names></name><name><surname>Heidinger</surname><given-names>BH</given-names></name><name><surname>Rainer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Reproducibility of 2D versus 3D radiomics for quantitative assessment of fetal lung development: a retrospective fetal MRI study</article-title><source>Insights Imaging</source><year>2023</year><volume>14</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s13244-023-01376-y</pub-id><pub-id pub-id-type="pmid">36752863</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Watzenboeck ML, Heidinger BH, Rainer J et al (2023) Reproducibility of 2D versus 3D radiomics for quantitative assessment of fetal lung development: a retrospective fetal MRI study. Insights Imaging 14:31. 10.1186/s13244-023-01376-y<pub-id pub-id-type="pmid">36752863</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Ai</surname><given-names>S</given-names></name><etal/></person-group><article-title>A radiomics nomogram analysis based on CT images and clinical features for preoperative Lauren classification in gastric cancer</article-title><source>Jpn J Radiol</source><year>2023</year><volume>41</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1007/s11604-022-01360-4</pub-id><pub-id pub-id-type="pmid">36370327</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Nie T, Liu D, Ai S et al (2023) A radiomics nomogram analysis based on CT images and clinical features for preoperative Lauren classification in gastric cancer. Jpn J Radiol 41:401&#x02013;408. 10.1007/s11604-022-01360-4<pub-id pub-id-type="pmid">36370327</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Preoperative prediction of Lauren classification in gastric cancer: a radiomics model based on dual-energy CT iodine map</article-title><source>Insights Imaging</source><year>2023</year><volume>14</volume><fpage>125</fpage><pub-id pub-id-type="doi">10.1186/s13244-023-01477-8</pub-id><pub-id pub-id-type="pmid">37454355</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Li M, Qin H, Yu X et al (2023) Preoperative prediction of Lauren classification in gastric cancer: a radiomics model based on dual-energy CT iodine map. Insights Imaging 14:125. 10.1186/s13244-023-01477-8<pub-id pub-id-type="pmid">37454355</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XX</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer</article-title><source>Cancer Imaging</source><year>2020</year><volume>20</volume><fpage>83</fpage><pub-id pub-id-type="doi">10.1186/s40644-020-00358-3</pub-id><pub-id pub-id-type="pmid">33228815</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Wang XX, Ding Y, Wang SW et al (2020) Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer. Cancer Imaging 20:83. 10.1186/s40644-020-00358-3<pub-id pub-id-type="pmid">33228815</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>